In the US, Mesalamine (mesalamine systemic) is a member of the drug class 5-aminosalicylates and is used to treat Crohn's Disease, Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Lymphocytic Colitis, Ulcerative Colitis, Ulcerative Colitis - Active, Ulcerative Colitis - Maintenance and Ulcerative Proctitis.
- Mesalamine rectal
- Mesalamine Long-Acting Capsules (Apriso)
- Mesalamine Long-Acting Capsules (Delzicol)
- Mesalamine Long-Acting Capsules (Pentasa)
- Mesalamine Rectal Enema
- Mesalamine Suppositories
- Mesalamine Tablets
- Mesalamine Controlled-Release Capsules
- Mesalamine Delayed Release Tablets
- Mesalamine Rectal Suspension
Ingredient matches for Mesalamine
Mesalamine (USAN) is also known as Mesalazine (Rec.INN)
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.